Abstract
We aimed to investigate the effect of propofol on the growth of human ovarian cancer cells ES2 and OVCAR-3 in vitro by regulating long non-coding RNA HOST2 (human ovarian cancer-specific transcript 2) and the inhibition of JAK2/STAT3 signaling pathway. In the present study, ES-2 and OVCAR-3 cells were firstly treated with different concentrations of propofol (0, 1, 5 and 10 μg/ml). The expression of HOST2 in ES-2 and OVCAR-3 cells were detected by quantitative reverse transcription-PCR (qRT-PCR). Then, the expression of HOST2 was changed by transfection of HOST2 overexpression plasmid into ES-2 and OVCAR-3 cells. Cell proliferation, migration, invasion and apoptosis were performed using CCK-8, wound-healing, Transwell assays and Flow Cytometry. Western blot analysis was performed to detect the expressions of apoptosis-associated proteins and JAK2/STAT3 pathway-related proteins. Results showed that cell viability and intracellular HOST2 expression in ES-2 and OVCAR-3 cells were decreased gradually with the increase of propofol concentration in a dose-dependent manner. Compared with the propofol group, overexpression of HOST2 significantly promoted the cell proliferation, migration, invasion and inhibited apoptosis, and ameliorated the inhibitory effect of propofol on the growth of tumor cells. Western blot analysis showed that compared with propofol group, the expression of Bcl-2 was significantly increased whereas Bax and the ratio of Cleaved caspase3/caspase3 were significantly decreased in pcDNA-HOST2 group. In addition, overexpression of HOST2 significantly enhanced the phosphorylation level of JAK2 and STAT3, and reduced the suppressive effect of propofol on JAK2/STAT3 signaling. Our results illustrated that propofol could significantly inhibit the proliferation, migration, invasion and induce apoptosis of ES-2 and OVCAR-3 cells by downregulating HOST2. The regulation mechanism may be achieved by inhibiting the activation of JAK2/STAT3 signaling pathway.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Baptista-Hon DT, Robertson FM, Robertson GB et al (2014) Potent inhibition by ropivacaine of metastatic colon cancer SW620 cell invasion and NaV1. 5 channel function. Br J Anaesth 113:39–48
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinic 68:394–424
Cata JP, Lasala J, Mena GE et al (2018) Anesthetic considerations for mediastinal staging procedures for lung cancer. J Cardiothorac Vasc Anesth 32:893–900
Chidambaran V, Costandi A, D’Mello A (2015) Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs 29:543–563
Colomiere M, Ward AC, Riley C et al (2009) Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas. Br J Cancer 100:134–144
D’Agostino G, Saporito A, Cecchinato V et al (2018) Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration. Br J Anaesth 121:962–968
Gao Y, Meng H, Liu S et al (2015a) LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet 24:841–852
Gao Y, Meng H, Liu S, Hu J, Zhang Y, Jiao T et al (2015b) LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet 24:841–852. https://doi.org/10.1093/hmg/ddu502 (PubMed PMID: 25292198)
Huang X, Teng Y, Yang H et al (2016) Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal. Braz J Med Biol Res 49:e5717
Kammar P, Bhatt A, Anam J et al (2019) Correlation between pelvic peritoneal disease and nodal metastasis in advanced ovarian cancer: can intraoperative findings define the need for systematic nodal dissection? Indian J Surg Oncol 10:84–90
Kim K, Jutooru I, Chadalapaka G et al (2013) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32:1616–1625
Levy DE, Inghirami G (2006) STAT3: a multifaceted oncogene. Proc Natl Acad Sci USA 103:10151–10152
Li H, Lu Y, Pang Y, Li M, Cheng X, Chen J (2017) Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway. Biomed Pharmacother 86:324–333. https://doi.org/10.1016/j.biopha.2016.12.036
Lin L, Liu C, Tan H et al (2011) Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth 106:814–822
Liu WZ, Liu N (2018) Propofol inhibits lung cancer A549 cell growth and epithelial-mesenchymal transition process by upregulation of MicroRNA-1284. Oncol Res Featuring Preclin Clin Cancer Therap 27:1–8
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
Oren-Ziv A, Hoppenstein D, Shles A et al (2015) Sedation methods for intra-articular corticosteroid injections in juvenile idiopathic arthritis: a review. Pediatr Rheumatol 13:28
Pandey MK, Sung B, Ahn KS et al (2009) Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1. Mol Pharmacol 75:525–533
Pujade-Lauraine E (2017) New treatments in ovarian cancer. Ann Oncol 28:viii57–viii60
Reyes R, Wani NA, Ghoshal K et al (2017) Sorafenib and 2-deoxyglucose synergistically inhibit proliferation of both sorafenib-sensitive and-resistant HCC cells by inhibiting ATP production. Gene Expr J Liver Res 17:129–140
Su Z, Hou XK, Wen QP (2014) Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression. Eur J Gynaecol Oncol 35:688–691
Tripathi MK, Doxtater K, Keramatnia F et al (2018) Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Drug Discov Today 23:1635–1643
Vasileiou I, Xanthos T, Koudouna E et al (2009) Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 605(1–3):1–8
Wang ZT, Gong HY, Zheng F et al (2015) Propofol suppresses proliferation and invasion of gastric cancer cells via downregulation of microRNA-221 expression. Genet Mol Res 14:8117–8124
Wang Q, Zhuang ZW, Cheng YM et al (2019) An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells. IUBMB Life 71:93–104
Wu Y, Zhang L, Wang Y et al (2014) Long noncoding RNA HOTAIR involvement in cancer. Tumor Biol 35:9531–9538
Wu Y et al (2018) Long Noncoding RNA HOST2 Promotes epithelial-mesenchymal transition, proliferation, invasion and migration of hepatocellular carcinoma cells by activating the JAK2-STAT3 signaling pathway. Cell Physiol Biochem 51:301–314. https://doi.org/10.1159/000495231
Wu Y, Yuan T, Wang WW et al (2018) Long noncoding RNA HOST2 promotes epithelial-mesenchymal transition, proliferation, invasion and migration of hepatocellular carcinoma cells by activating the JAK2-STAT3 signaling pathway. Cell Physiol Biochem 51:301–314
Xu K, Tao W, Su Z (2018) Propofol prevents IL-13-induced epithelial–mesenchymal transition in human colorectal cancer cells. Cell Biol Int 42:985–993
Yang G, Rosen DG, Liu G et al (2010) CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res 16:3875–3886
Zhang Y, Zhang H, Kang H et al (2019) Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis. Int J Mol Med 43:1049–1057
Zhou M, Wang X, Shi H et al (2016) Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget 7:12598
Zhou C, Li J, Ji P (2017) Propofol suppresses esophageal squamous cell carcinoma cell migration and invasion by down-regulation of sex-determining region Y-box 4 (SOX4). Med Sci Monit Int Med J Exp Clin Res 23:419
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
XS and JP made substantial contributions to the conception and design of the present study. XS designed the research; XS, DW and XC performed the research; XS and DW analyzed the data and wrote the paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shen, X., Wang, D., Chen, X. et al. Propofol inhibits proliferation, migration, invasion and promotes apoptosis by regulating HOST2/JAK2/STAT3 signaling pathway in ovarian cancer cells. Cytotechnology 73, 243–252 (2021). https://doi.org/10.1007/s10616-021-00462-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-021-00462-7